Organon Quarterly Balance Sheet
NYSE: OGNHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Organon financial position
As of Jun 30, 2026, Organon reported total assets of $13.18 billion, down 2.4% from a year earlier against total liabilities of $12.17 billion. Shareholders' equity stood at $1.01 billion, or 7.6% of assets. The company held $1.13 billion in cash and equivalents against $8.55 billion of debt, a net debt position of $7.42 billion.
The current ratio (current assets divided by current liabilities) was 1.95, meaning short-term assets cover obligations due within a year. Debt-to-equity was 8.50.
Summary generated from market data by MetaCap's automated system. Methodology
Organon balance sheet (quarterly)
| Quarter (USD) | Q2 20262026-06-30 | Q1 20262026-03-31 | Q4 20252025-12-31 | Q3 20252025-09-30 | Q2 20252025-06-30 | Q1 20252025-03-31 | Q4 20242024-12-31 | Q3 20242024-09-30 | Q2 20242024-06-30 | Q1 20242024-03-31 | Q4 20232023-12-31 | Q3 20232023-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 1.13B | 1.12B | 574.00M | 672.00M | 599.00M | 547.00M | 675.00M | 763.00M | 704.00M | 575.00M | 693.00M | 414.00M |
| Receivables | 1.49B | 1.38B | 1.33B | 1.48B | 1.48B | 1.46B | 1.36B | 1.69B | 1.62B | 1.55B | 1.74B | 1.65B |
| Inventory | 1.35B | 1.37B | 1.41B | 1.49B | 1.45B | 1.36B | 1.32B | 1.38B | 1.29B | 1.26B | 1.31B | 1.19B |
| Total Current Assets | 5.11B | 4.93B | 4.35B | 4.70B | 4.62B | 4.37B | 4.35B | 4.76B | 4.51B | 4.20B | 4.51B | 4.05B |
| Property, Plant & Equipment | 1.28B | 1.28B | 1.30B | 1.29B | 1.27B | 1.20B | 1.17B | 1.20B | 1.16B | 1.18B | 1.18B | 1.10B |
| Goodwill | 4.15B | 4.15B | 4.15B | 4.68B | 4.68B | 4.68B | 4.68B | 4.60B | 4.60B | 4.60B | 4.60B | 4.60B |
| Intangible Assets | 1.11B | 1.10B | 1.13B | 1.34B | 1.36B | 1.42B | 1.41B | 763.00M | 684.00M | 718.00M | 533.00M | 561.00M |
| Total Assets | 13.18B | 13.00B | 12.87B | 13.55B | 13.50B | 13.16B | 13.10B | 12.75B | 12.15B | 11.89B | 12.06B | 11.01B |
| Accounts Payable | 1.05B | 983.00M | 952.00M | 1.07B | 1.07B | 1.01B | 1.15B | 1.09B | 1.24B | 955.00M | 1.31B | 1.07B |
| Short-Term Debt | 74.00M | 16.00M | 16.00M | 45.00M | 115.00M | 20.00M | 20.00M | 10.00M | 9.00M | 9.00M | 9.00M | 8.00M |
| Total Current Liabilities | 2.62B | 2.50B | 2.39B | 2.68B | 2.80B | 2.62B | 2.72B | 2.79B | 2.75B | 2.54B | 2.92B | 2.49B |
| Long-Term Debt | 8.48B | 8.55B | 8.63B | 8.78B | 8.78B | 8.94B | 8.86B | 8.74B | 8.65B | 8.71B | 8.75B | 8.65B |
| Total Liabilities | 12.17B | 12.09B | 12.12B | 12.65B | 12.77B | 12.61B | 12.63B | 12.26B | 12.01B | 11.84B | 12.13B | 11.60B |
| Shareholders' Equity | 1.01B | 903.00M | 752.00M | 906.00M | 733.00M | 542.00M | 472.00M | 493.00M | 144.00M | 48.00M | -70.00M | -589.00M |
| Retained Earnings | 1.35B | 1.25B | 1.11B | 1.32B | 1.16B | 1.03B | 1.01B | 975.00M | 690.00M | 573.00M | 443.00M | -16.00M |
| Total Debt | 8.55B | 8.57B | 8.64B | 8.83B | 8.90B | 8.96B | 8.88B | 8.75B | 8.66B | 8.71B | 8.76B | 8.65B |
| Net Cash (Debt) | -7.42B | -7.45B | -8.07B | -8.16B | -8.30B | -8.41B | -8.21B | -7.99B | -7.95B | -8.14B | -8.07B | -8.24B |
| Shares Outstanding | 262.61M | 262.65M | 260.32M | 259.98M | 259.96M | 257.95M | 257.80M | 257.54M | 257.47M | 255.85M | 255.63M | 255.61M |
This table shows 12 quarterly periods of Organon's balance sheet, from Q2 2026 back to Q3 2023, across 18 line items including cash & equivalents, receivables, inventory. Values in USD; B = billions, M = millions. Fiscal periods follow OGN's reporting calendar. What is a balance sheet?